Overview

Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:

Status:
Recruiting
Trial end date:
2023-02-15
Target enrollment:
Participant gender:
Summary
The relative increase in the mPAP with the same unit increase in MAP adjusted for baseline, and RV function assessed by GLS, between VP and NE in patients with normal and increased pulmonary artery pressure, who require vasopressor support during cardiac surgery.
Phase:
Phase 3
Details
Lead Sponsor:
The Cleveland Clinic
Treatments:
Arginine Vasopressin
Norepinephrine
Vasopressins